Crossref

1. Controversial Concepts Regarding T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients

- Mojgan Noroozi Karimabad

- Gholamhossein Hassanshahi

- Mohammad Kazemi Arababadi

2. T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses

- Elahe Aleebrahim-Dehkordi

- Bahareh Molavi

- Melika Mokhtari

- Niloofar Deravi

- Mobina Fathi

- Tara Fazel

- Mehdi Mohebalizadeh

- Pooneh Koochaki

- Parnian Shobeiri

- Ali Hasanpour-Dehkordi

3. Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder

- Carolina Rosadas

- Ana C. P. Vicente

- Louise Zanella

- Mauro J. Cabral-Castro

- José M. Peralta

- Marzia Puccioni-Sohler

4. Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitis

- Antonia Mourtzikou

- Maria Alepaki

- Marilena Stamouli

- Abraham Pouliakis

- Anastasios Skliris

- Petros Karakitsos

5. Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10

- Soriane de Souza-Cruz

- Marilú Barbieri Victória

- Andréa Monteiro Tarragô

- Allyson Guimarães da Costa

- João Paulo Diniz Pimentel

- Ericka Florêncio Pires

- Lorene de Paula Araújo

- Jordana Grazziela Coelho-dos-Reis

- Matheus de Souza Gomes

- Laurence Rodrigues Amaral

- Andréa Teixeira-Carvalho

- Olindo Assis Martins-Filho

- Flamir da Silva Victória

- Adriana Malheiro

6. Methodological and Statistical Comments on T Helper Cytokines Profile and Hepatitis C

- Ali Kabir

7. Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection

- Najmeh Rokhtabnak

- Mohammad Reza Ataollahi

- Morvarid Asadipour

- Mohammad Ali-Hassanzadeh

- Pooria Fazeli

- Soolmaz Khansalar

- Esmaeel Ghani

- Kurosh Kalantar

8. Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection

- Jacinta A. Holmes

- Charles Carlton‐Smith

- Arthur Y. Kim

- Emily O. Dumas

- Joelle Brown

- Jenna L. Gustafson

- Georg M. Lauer

- Sakuni T. Silva

- Maxwell Robidoux

- Daniel Kvistad

- Nadia Alatrakchi

- Pierre Tonnerre

- Daniel E. Cohen

- Hongtao Zhang

- Nancy S. Shulman

- Raymond T. Chung

9. First report of HTLV-1 truncated p12 protein in Brazil

- Carolina Rosadas

- Ana C. P. Vicente

- Louise Zanella

- Mauro J. Cabral-Castro

- José M. Peralta

- Marzia Puccioni-Sohler

10. Association of IL‐1β, IL‐1RN, and ESR1 genes polymorphism with risk of infection and response to sofosbuvir plus daclatasvir combination therapy in hepatitis C virus genotype‐4 patients

- Rasha M. Khairy

- Hend M. Abdulghany

- Salama Abdel‐Raheim

- Nagwa M. Zenhom

- Aliaa S Abd Elfatah

- Nilly H. Abdalla

11. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology

- Helal F Hetta

- Mohamed A Mekky

- Nasr K Khalil

- Wegdan A Mohamed

- Mohamed A El‐Feky

- Shabaan H Ahmed

- Enas A Daef

- Mahmoud I Nassar

- Ahmed Medhat

- Kenneth E Sherman

- Mohamed Tarek M Shata

12. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C

- Geison Luiz Costa de Castro

- Carlos David A. Bichara

- Angélica Menezes Santiago

- William Botelho de Brito

- Leonn Mendes Soares Pereira

- Tuane Carolina Ferreira Moura

- Ednelza da Silva Graça Amoras

- Mauro Sérgio Moura de Araújo

- Simone Regina Souza da Silva Conde

- Maria Alice Freitas Queiroz

- Ricardo Ishak

- Antonio Carlos Rosário Vallinoto

13. Cytokine profile in chronic hepatitis C: An observation

- Dejan Baskic

- Vuk R. Vukovic

- Suzana Popovic

- Predrag Djurdjevic

- Milan Zaric

- Ivana Nikolic

- Ivanka Zelen

- Marina Mitrovic

- Dusko Avramovic

- Zeljko Mijailovic

14.

15. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

- María Abad-Fernández

- Ana Moreno

- Fernando Dronda

- Santos del Campo

- Carmen Quereda

- José Luis Casado

- María-Jesús Pérez-Elías

- Santiago Moreno

- Alejandro Vallejo

16. HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8+ T-cell-based vaccines and immunotherapies

- Laura Cardoso Corrêa-Dias

- Ágata Lopes-Ribeiro

- Geovane Marques-Ferreira

- Letícia Gomes-de-Pontes

- Thaiza Aline Pereira-Santos

- Erik Vinicius de Sousa Reis

- Thaís de Fátima Silva Moraes

- Olindo Assis Martins-Filho

- Edel Figueiredo Barbosa-Stancioli

- Flávio Guimarães da Fonseca

- Jordana Grazziela Coelho-dos-Reis

17. Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection

- Seyed Hedayat Hosseini Khorami

- Foroogh Nejatollahi

- Mohammad Ali Davarpanah

18. Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV

- María Q. Marín

- Kwinten Sliepen

- Juan García-Arriaza

- Sylvie M. Koekkoek

- Patricia Pérez

- Carlos Óscar S. Sorzano

- Carmen E. Gómez

- Rogier W. Sanders

- Mariano Esteban

19. Low Mannose Binding Lectin, but Not L-Ficolin, Is Associated With Spontaneous Clearance of Hepatitis C Virus After Infection

- Jing Zhang

- Ning Chen

- Zhiyun Chen

- Yali Liu

- Kai Zheng

- Yundong Qiu

- Nan Zhang

- Junping Zhu

- Haibin Yu

- Qiushui He

20. The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran

- Jamal Sarvari

- Hossin Norozian

- Mohamad Reza Fattahi

- Neda Pirbonyeh

- Afagh Moattari